Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2005Cancer ResearchOpen Access

Aberrant Epidermal Growth Factor Receptor Signaling and Enhanced Sensitivity to EGFR Inhibitors in Lung Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

JAJoseph M. AmannThe Ohio State UniversitySKShailaja KalyankrishnaThe University of Texas MD Anderson Cancer CenterPMPierre P. MassionVanderbilt University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Amann et al. (2005) studied this question.

synapsesocial.com/papers/6a0ce93ed2f99fbc58fc0b92https://doi.org/10.1158/0008-5472.226.65.1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors2002 · 1,130 citations
  2. 2Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer2003 · 2,541 citations